The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial
暂无分享,去创建一个
L. Appel | A. Dalcin | A. Wolff | C. Snyder | Robert S. Miller | G. Jerome | J. Coughlin | D. Sharma | A. Blackford | V. Stearns | D. Armstrong | G. Cohen | K. Smith | M. Armanios | J. Fetting | Colleen C. Schreyer | R. Connolly | A. Wolfe | C. Santa-Maria | Chiung-Yu Huang | A. Carpenter | M. Chaudhry
[1] T. Louis,et al. Cost of behavioral weight loss programs implemented in clinical practice: The POWER trial at Johns Hopkins. , 2019, Translational behavioral medicine.
[2] Dorothy D. Sears,et al. The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes , 2018, Journal of the National Cancer Institute.
[3] G. Jerome,et al. Obese Breast Cancer Patients and Survivors: Management Considerations. , 2018, Oncology.
[4] L. Pusztai,et al. Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study , 2018, Breast Cancer Research and Treatment.
[5] Margaret A. Strong,et al. Diagnostic utility of telomere length testing in a hospital-based setting , 2018, Proceedings of the National Academy of Sciences.
[6] T. Wadden,et al. Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design , 2017, npj Breast Cancer.
[7] S. Chen,et al. Central obesity and risks of pre‐ and postmenopausal breast cancer: a dose–response meta‐analysis of prospective studies , 2016, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[8] L. Rochette,et al. Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Gary H Lyman,et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] A. Chagpar,et al. Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] N. Samani,et al. Reproducibility of telomere length assessment: an international collaborative study , 2014, International journal of epidemiology.
[12] G. Colditz,et al. Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] G. Pond,et al. Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] D. Sharma,et al. Multifaceted Leptin Network: The Molecular Connection Between Obesity and Breast Cancer , 2013, Journal of Mammary Gland Biology and Neoplasia.
[15] Jue Lin,et al. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. , 2013, The Lancet. Oncology.
[16] David N. Rider,et al. Telomere Length Varies By DNA Extraction Method: Implications for Epidemiologic Research , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[17] E. Perez,et al. Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer , 2012, Cancer.
[18] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[19] K. Gelmon,et al. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity. , 2012, Journal of the Academy of Nutrition and Dietetics.
[20] Thomas A Louis,et al. Comparative effectiveness of weight-loss interventions in clinical practice. , 2011, The New England journal of medicine.
[21] Lily Yang,et al. Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells. , 2011, Endocrine-related cancer.
[22] V. Vance,et al. Weight gain in breast cancer survivors: prevalence, pattern and health consequences , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[23] A. Stopeck,et al. Changes in Body Weight and Metabolic Indexes in Overweight Breast Cancer Survivors Enrolled in a Randomized Trial of Low-Fat vs. Reduced Carbohydrate Diets , 2010, Nutrition and cancer.
[24] E. Yeh,et al. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. , 2009, Journal of the American College of Cardiology.
[25] F. Anania,et al. Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. , 2008, Cancer research.
[26] Jue Lin,et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. , 2008, The Lancet. Oncology.
[27] Martin Wiseman,et al. The Second World Cancer Research Fund/American Institute for Cancer Research Expert Report. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective , 2008, Proceedings of the Nutrition Society.
[28] V. Stearns. A diet low in fat and high in vegetables, fruit, and fiber following breast cancer treatment did not reduce new breast cancer events. , 2008, ACP journal club.
[29] M. Pencina,et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. , 2007, JAMA.
[30] Loki Natarajan,et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. , 2007, JAMA.
[31] P. Judd,et al. Randomized controlled trial comparing a low‐fat diet with a weight‐reduction diet in breast cancer‐related lymphedema , 2007, Cancer.
[32] Dipali Sharma,et al. Leptin-induced Growth Stimulation of Breast Cancer Cells Involves Recruitment of Histone Acetyltransferases and Mediator Complex to CYCLIN D1 Promoter via Activation of Stat3* , 2007, Journal of Biological Chemistry.
[33] P. Lansdorp,et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.
[34] J. Danesh,et al. Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies , 2007, Circulation.
[35] Robert M Elashoff,et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.
[36] P. Lansdorp,et al. Flow cytometry and FISH to measure the average length of telomeres (flow FISH) , 2006, Nature Protocols.
[37] N. Boyd,et al. Weight gain during adjuvant chemotherapy for breast cancer , 2005, Breast Cancer Research and Treatment.
[38] R. Ross,et al. Waist circumference and not body mass index explains obesity-related health risk. , 2004, The American journal of clinical nutrition.
[39] L. Darga,et al. Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors. , 2002, Obesity research.
[40] K. Nakachi,et al. [Telomere length in breast carcinoma of the young and aged]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.
[41] Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. , 1997, Archives of internal medicine.
[42] M. McCullough,et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. , 1995, Annals of epidemiology.
[43] K. Vranizan,et al. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. , 1988, The New England journal of medicine.
[44] M. Kimura,et al. Biological characteristics of breast cancer in obesity. , 1976, The Tohoku journal of experimental medicine.